MedPath

Detection of precancer cervical lesions with methylation markers in urine

Recruiting
Conditions
Methylation markers, cervix carcinoma, CIN2, CIN3, CIN, urine analysis
Registration Number
NL-OMON23501
Lead Sponsor
VUmc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

>18 years old

- eligible for LLETZ

Exclusion Criteria

- other cancer elsewhere

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concordance between HPV DNA detection and DNA methylation analysis in urine and a cervicovaginal self sample
Secondary Outcome Measures
NameTimeMethod
Performance of biomarkers in urine for detection of CIN2+ or CIN3+, and compared with the performance of this test in cervicovaginal self samples <br>
© Copyright 2025. All Rights Reserved by MedPath